{"id":"W1975365119","doi":"10.1086/318809","title":"A Phase 1/2 Clinical Trial of Enzyme Replacement in Fabry Disease: Pharmacokinetic, Substrate Clearance, and Safety Studies","year":2001,"lang":"en","type":"article","venue":"The American Journal of Human Genetics","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":383,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; National Center for Research Resources; McGill University","keywords":"Pharmacokinetics; Medicine; Enzyme replacement therapy; Globotriaosylceramide; Kidney; Fabry disease; Internal medicine; Clearance; Pharmacology; Endocrinology; Pathology; Gastroenterology; Urology; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1037982530427376,"score_gpt":0.4664230837248811,"score_spread":0.3626248306821435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}